EFSA (European Food Safety Authority) et al., 2024 - Google Patents

Statement on the toxicological properties and maximum residue levels of acetamiprid and its metabolites

EFSA (European Food Safety Authority) et al., 2024

View PDF @Full View
Document ID
14704272974377469940
Author
EFSA (European Food Safety Authority)
Hernandez‐Jerez A
Coja T
Paparella M
Price A
Henri J
Focks A
Louisse J
Terron A
Binaglia M
Guajardo I
Mangas I
Guajardo I
Ferreira L
Kardassi D
De Lentdecker C
Molnar T
Vianello G
Publication year
Publication venue
EFSA Journal

External Links

Snippet

Acetamiprid is a pesticide active substance with insecticidal action whose approval was renewed by Commission Implementing Regulation (EU) 2018/113. In January 2022, the EFSA PPR Panel published a statement following a request from the European Commission …
Continue reading at efsa.onlinelibrary.wiley.com (PDF) (other versions)

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5082—Supracellular entities, e.g. tissue, organisms
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/502—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G—PHYSICS
    • G06—COMPUTING; CALCULATING; COUNTING
    • G06F—ELECTRICAL DIGITAL DATA PROCESSING
    • G06F19/00—Digital computing or data processing equipment or methods, specially adapted for specific applications
    • G06F19/30—Medical informatics, i.e. computer-based analysis or dissemination of patient or disease data
    • G06F19/36—Computer-assisted acquisition of medical data, e.g. computerised clinical trials or questionnaires
    • G—PHYSICS
    • G06—COMPUTING; CALCULATING; COUNTING
    • G06Q—DATA PROCESSING SYSTEMS OR METHODS, SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL, SUPERVISORY OR FORECASTING PURPOSES; SYSTEMS OR METHODS SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL, SUPERVISORY OR FORECASTING PURPOSES, NOT OTHERWISE PROVIDED FOR
    • G06Q50/00—Systems or methods specially adapted for a specific business sector, e.g. utilities or tourism
    • G06Q50/10—Services
    • G06Q50/22—Health care, e.g. hospitals; Social work

Similar Documents

Publication Publication Date Title
Liu et al. Sucrose preference test for measurement of stress-induced anhedonia in mice
Andersen et al. Pyrethroids and developmental neurotoxicity-A critical review of epidemiological studies and supporting mechanistic evidence
Burns et al. Pyrethroid epidemiology: a quality-based review
Preston et al. Exacerbated craving in the presence of stress and drug cues in drug-dependent patients
Deacon Assessing nest building in mice
Bal-Price et al. International STakeholder NETwork (ISTNET): creating a developmental neurotoxicity (DNT) testing road map for regulatory purposes
Koolhaas et al. The resident-intruder paradigm: a standardized test for aggression, violence and social stress
Kamakura et al. The effects of group and single housing and automated animal monitoring on urinary corticosterone levels in male C57 BL/6 mice
Goad et al. Carbofuran-induced endocrine disruption in adult male rats
Conour et al. Preparation of animals for research—issues to consider for rodents and rabbits
Gwaltney-Brant Veterinary forensic toxicology
Varholick et al. Phenotypic variability between Social Dominance Ranks in laboratory mice
Hinchcliffe et al. Further validation of the affective bias test for predicting antidepressant and pro-depressant risk: effects of pharmacological and social manipulations in male and female rats
Messias et al. Dopamine disruption increases negotiation for cooperative interactions in a fish
EFSA Panel on Plant Protection Products and their Residues (EFSA PPR Panel) et al. Development of Integrated Approaches to Testing and Assessment (IATA) case studies on developmental neurotoxicity (DNT) risk assessment
Beery et al. Social selectivity and social motivation in voles
Kast et al. Long‐term monitoring of lipophilic acaricide residues in commercial Swiss beeswax
EFSA (European Food Safety Authority) et al. Statement on the toxicological properties and maximum residue levels of acetamiprid and its metabolites
Kimmel et al. Recent developments in regulatory requirements for developmental toxicology
Dupoué et al. Water deprivation increases maternal corticosterone levels and enhances offspring growth in the snake Vipera aspis
Xu et al. Making sense of pharmacovigilance and drug adverse event reporting: comparative similarity association analysis using AI machine learning algorithms in dogs and cats
Hohlbaum et al. Social enrichment by separated pair housing of male C57BL/6JRj mice
EFSA Panel on Plant Protection Products and their Residues (PPR) et al. Statement on the active substance acetamiprid
Li et al. Research progress of zebrafish model in aquatic ecotoxicology
Sgargi et al. Protocol for a systematic review and meta-analysis of human exposure to pesticide residues in honey and other bees’ products